Grady J

ORCID: 0000-0001-9667-3872 · 1 paper in corpus

nonrandomized-trial 2025

Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical Trial

JAMA oncology ·doi:10.1001/jamaoncol.2025.1916

IMPORTANCE: Gynecological clear cell cancers (CCCs) are aggressive malignant neoplasms with low response rate to chemotherapy. The treatment of patients with metastatic disease remains an area of significant unmet need. OBJECTIVE: To evalu…